January 19, 2018 / 9:32 AM / 7 months ago

BRIEF-Sangui Biotech: Revenues Of $54,000 In H1

Reuters Staff

1 Min Read

Jan 19 (Reuters) - SANGUI BIOTECH INTERNATIONAL INC :

* DGAP-NEWS: SANGUI BIOTECH INTERNATIONAL INC.: - REVENUES OF USD 54,000 IN THE FIRST HALF-YEAR; GRANULOX LICENSE INCOME INCREASED BY 54%.

* REVENUES OF USD 54,000 IN FIRST HALF-YEAR; Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0